These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38396064)
1. Comprehensive analyses of solute carrier family members identify SLC12A2 as a novel therapy target for colorectal cancer. Chen DY; Zhang YY; Nie HH; Wang HZ; Qiu PS; Wang F; Peng YN; Xu F; Zhao Q; Zhang M Sci Rep; 2024 Feb; 14(1):4459. PubMed ID: 38396064 [TBL] [Abstract][Full Text] [Related]
2. Identification of a Six-Gene SLC Family Signature With Prognostic Value in Patients With Lung Adenocarcinoma. Zhu J; Mou Y; Ye S; Hu H; Wang R; Yang Q; Hu Y Front Cell Dev Biol; 2021; 9():803198. PubMed ID: 34977043 [TBL] [Abstract][Full Text] [Related]
3. Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer. Huang A; Sun Z; Hong H; Yang Y; Chen J; Gao Z; Gu J J Transl Med; 2024 Jun; 22(1):587. PubMed ID: 38902737 [TBL] [Abstract][Full Text] [Related]
4. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction. Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226 [TBL] [Abstract][Full Text] [Related]
5. Molecular subtype identification and prognosis stratification by a metabolism-related gene expression signature in colorectal cancer. Lin D; Fan W; Zhang R; Zhao E; Li P; Zhou W; Peng J; Li L J Transl Med; 2021 Jun; 19(1):279. PubMed ID: 34193202 [TBL] [Abstract][Full Text] [Related]
6. Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer. Zhou M; Lv S; Hou Y; Zhang R; Wang W; Yan Z; Li T; Gan W; Zeng Z; Zhang F; Yang M Front Immunol; 2022; 13():994874. PubMed ID: 36330513 [TBL] [Abstract][Full Text] [Related]
7. Development and validation of cuproptosis-related lncRNA signatures for prognosis prediction in colorectal cancer. Pang L; Wang Q; Wang L; Hu Z; Yang C; Li Y; Wang Z; Li Y BMC Med Genomics; 2023 Mar; 16(1):58. PubMed ID: 36949429 [TBL] [Abstract][Full Text] [Related]
8. Co-expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer. Zhang Y; Liu Z; Li L; Zeng D; Sun H; Wu J; Zhou R; Liao W J Cell Mol Med; 2023 Dec; 27(24):4181-4194. PubMed ID: 37909856 [TBL] [Abstract][Full Text] [Related]
9. System analysis based on the cuproptosis-related genes identifies LIPT1 as a novel therapy target for liver hepatocellular carcinoma. Yan C; Niu Y; Ma L; Tian L; Ma J J Transl Med; 2022 Oct; 20(1):452. PubMed ID: 36195876 [TBL] [Abstract][Full Text] [Related]
10. Stemness Refines the Classification of Colorectal Cancer With Stratified Prognosis, Multi-Omics Landscape, Potential Mechanisms, and Treatment Options. Liu Z; Xu H; Weng S; Ren Y; Han X Front Immunol; 2022; 13():828330. PubMed ID: 35154148 [TBL] [Abstract][Full Text] [Related]
11. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer. Yang C; Cao F; Huang S; Zheng Y Front Immunol; 2021; 12():717505. PubMed ID: 34335633 [TBL] [Abstract][Full Text] [Related]
12. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer. Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366 [TBL] [Abstract][Full Text] [Related]
13. Characterization of butyrate-metabolism in colorectal cancer to guide clinical treatment. Luo Q; Zhou P; Chang S; Huang Z; Zeng X Sci Rep; 2023 Mar; 13(1):5106. PubMed ID: 36991138 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Solute Carrier Family-Based Signature for Predicting Overall Survival in Osteosarcoma. Zheng D; Wei Z; Guo W Front Genet; 2022; 13():849789. PubMed ID: 35518353 [TBL] [Abstract][Full Text] [Related]
15. Identification of a five-gene signature with prognostic value in colorectal cancer. Sun G; Li Y; Peng Y; Lu D; Zhang F; Cui X; Zhang Q; Li Z J Cell Physiol; 2019 Apr; 234(4):3829-3836. PubMed ID: 30132881 [TBL] [Abstract][Full Text] [Related]
16. Identification of cuproptosis-related subtypes and development of a prognostic signature in colorectal cancer. Huang Y; Yin D; Wu L Sci Rep; 2022 Oct; 12(1):17348. PubMed ID: 36253436 [TBL] [Abstract][Full Text] [Related]
17. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis. Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544 [TBL] [Abstract][Full Text] [Related]
18. Characterization of stem cell landscape and identification of stemness-relevant prognostic gene signature to aid immunotherapy in colorectal cancer. Zheng H; Liu H; Li H; Dou W; Wang J; Zhang J; Liu T; Wu Y; Liu Y; Wang X Stem Cell Res Ther; 2022 Jun; 13(1):244. PubMed ID: 35681225 [TBL] [Abstract][Full Text] [Related]
19. Establishment of a circular RNA regulatory stemness-related gene pair signature for predicting prognosis and therapeutic response in colorectal cancer. Chen Q; Tang P; Huang H; Qiu X Front Immunol; 2022; 13():934124. PubMed ID: 35958575 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of oxidative stress-related genes in colorectal cancer and its correlation with tumor immunity. Yang L; Fang C; Zhang R; Zhou S BMC Genomics; 2024 Jan; 25(1):8. PubMed ID: 38166604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]